US Bancorp’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-250
Closed -$770 4216
2025
Q4
$770 Hold
250
﹤0.01% 3889
2025
Q3
$908 Hold
250
﹤0.01% 3837
2025
Q2
$1.05K Hold
250
﹤0.01% 3951
2025
Q1
$835 Hold
250
﹤0.01% 4002
2024
Q4
$1.04K Sell
250
-484
-66% -$2.03K ﹤0.01% 3951
2024
Q3
$2.68K Sell
734
-964
-57% -$3.82K ﹤0.01% 3717
2024
Q2
$8.15K Buy
1,698
+1,122
+195% +$6.29K ﹤0.01% 3381
2024
Q1
$4.51K Sell
576
-644
-53% -$5.07K ﹤0.01% 3552
2023
Q4
$14.3K Buy
1,220
+970
+388% +$9.51K ﹤0.01% 3185
2023
Q3
$2.47K Hold
250
﹤0.01% 3610
2023
Q2
$2.83K Hold
250
﹤0.01% 3617
2023
Q1
$2.61K Sell
250
-178
-42% -$1.7K ﹤0.01% 3689
2022
Q4
$3.46K Buy
428
+36
+9% +$315 ﹤0.01% 3630
2022
Q3
$3K Buy
392
+76
+24% +$907 ﹤0.01% 3725
2022
Q2
$4K Sell
316
-230
-42% -$3.01K ﹤0.01% 3637
2022
Q1
$8K Buy
+546
New +$9.34K ﹤0.01% 3450

Other funds holding EVO

US Bancorp's EVO Position: Q1 2026 in Review

US Bancorp sold out of Evotec (EVO) in Q1 2026, closing a stake of 250 shares — an estimated $770 sold.

US Bancorp first reported a position in EVO in Q1 2022 and held it in 16 quarters. The position peaked at $14.3K in Q4 2023. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • US Bancorp reported no remaining Evotec position as of Q1 2026 after selling out during the quarter.
  • US Bancorp sold 250 Evotec shares in Q1 2026, an estimated $770.
  • US Bancorp first reported a position in Evotec in Q1 2022 and held it in 16 quarters.
  • US Bancorp's Evotec position peaked at $14.3K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.